Glutathione Metabolism in Glia and Neurons
Background
Reactive oxygen species (ROS), produced continuously during oxidative metabolism, are generated at high rates within the brain. The human brain cells utilize 20% of the oxygen consumed by the body but constitute only 2% of the body weight. In the brain, there is a large quantity of ROS generated during oxidative phosphorylation. Compared to other organs, the brain appears to be in an unfavorable position regarding generation and ROS detoxification. Therefore, one of the essential tasks within the brain is the defense against the toxic effects of ROS. The involvement of the antioxidant glutathione (GSH) in this process is very important. GSH is involved in the disposal of peroxides by brain cells and the protection against reactive oxygen species.
Functions of GSH
GSH is a tripeptide and present in most cell types, including astrocytes. GSH has some important physiological functions. For example, Cellular detoxification of ROS need for GSH. Besides intracellular functions, GSH also has important extracellular functions in the brain. In addition, to its chemical reaction with radicals and electrophiles, GSH serves as a substrate or cofactor of many detoxifying cellular enzymes. Furthermore, it can act as an antioxidant, a modulator of glutamatergic signaling, and a cysteine transport form.
Fig.1 Function of GSH as an antioxidant. (Dringen, 2000)
GSH Synthesis in Brain
In general, the GSH tripeptide is synthesized as the product by two ATP-consuming cytosolic enzymes. In the first step of GSH synthesis, g-Glutamylcysteine (gGluCys) synthetase uses glutamate and cysteine as substrates and forms the dipeptide gGluCys. In the second step of GSH synthesis, L-γ-glutamylcysteine and ATP combine to form L-γ-glutamyl-cysteinyl phosphate, which is combined with glycine in a reaction catalyzed by GSH synthase to form GSH. The synthesis of GSH depends on the intracellular availability of the substrates. This synthesis could occur in both neurons and glial cells, although astrocytes synthesize GSH more effectively than neurons because of their ability to utilize a wider variety of precursor substrates.
GSH Metabolism
During detoxification of ROS, GSH is involved in two types of reactions: (i) GSH reacts with radicals such as the superoxide radical anion, nitric oxide, or the hydroxyl radical, and (ii) GSH is the electron donor for the reduction of peroxides in the GSH peroxidases (GPx) reaction. The product of GSH oxidation is GSH disulfide (GSSG), and GPx catalyzes this reaction. GSH is regenerated from GSSG by the GSH reductase (GR) reaction within cells. In contrast, through the formation of GSH S-conjugates by GSH S-transferases (GSTs), enzymes present in the brain, and by the export of GSH or GSSG from cells, the level of total intracellular GSH is lowered. Such processes also participate in the consumption of GSH in brain cells.
Fig.2 Metabolism of GSH. (Dringen, 2000)
Metabolic Cooperation in GSH Metabolism
Metabolic cooperation between astrocytes and neurons is much important for the homeostasis of GSH in the brain. In the brain, especially neurons appear to be disadvantaged regarding GSH metabolism. GSH synthesis in neurons relies on extracellular cysteine and cannot use the cysteine-oxidation product cystine as a GSH precursor. However, astrocytes can utilize a far greater number of other amino acids, metabolites, or peptides as precursors of the GSH synthesis substrates glutamate, cysteine, or glycine. Thus, astrocytes have a pivotal role in the brain as partners of neurons in homeostatic and metabolic processes.
Extracellular GSH is a key requirement for the metabolic interaction between astrocytes and neurons in GSH metabolism. Thus, the intensive metabolic exchange occurs between astrocytes and neurons in which one of the interactions is the supply by astrocytes of GSH precursors to neurons. This interaction also appears to be important regarding cerebral GSH homeostasis and the protection of the brain against oxidative stress. In the presence of astroglial cells, neurons maintain the GSH levels and are protected against the ROS-induced toxicity of various compounds and treatments. Therefore, disturbances of this metabolic interaction between astrocytes and neurons will affect GSH homeostasis in the brain and contribute to a compromised antioxidative defense in neurological diseases.
Fig.3 Scheme of the proposed metabolic interaction between astrocytes and neurons in GSH metabolism. (Dringen, 2000)
Implications of Disturbed GSH Metabolism for Neurodegenerative Diseases
Insufficient antioxidative defense or increased generation of ROS can cause oxidative stress. For the brain, oxidative stress has related to the loss of neurons during the progression of neurological diseases, e.g., Parkinson’s disease (PD), Alzheimer’s disease, schizophrenia, Huntington’s disease, and stroke. Thus, impairments in GSH-dependent detoxification processes in astrocytes and neurons are likely to contribute to disturbances in brain GSH homeostasis as well as to neural damage.
For example, the best evidence for a disturbed GSH metabolism in the brain as the factor leading to the pathogenesis of a disease has been reported for PD. The observation that certain GSTs are expressed in brain regions affected in Parkinson’s disease and change expression in PD models. Because GSTs are modulated by several actions that induce oxidative stress, measurement of this class of proteins may allow the identification of individuals in which this process is aberrant. Many different therapeutical treatments for PD have been under investigation. Since a compromised GSH system appears to be an early event during the pathogenesis of PD, improvement of either GSH levels or activities of enzymes involved in GSH metabolism has been considered treatment strategies.
As a global pioneer leader in neurosciences, Creative Biolabs is professional in applying a series of leading technologies and products for our customers worldwide. If you want to know more about our services and products, please do not hesitate to contact us for more detailed information.
References
- Dringen, R.; et al. Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. European journal of biochemistry. 2000, 267(16), 4912-4916.
- Dringen, R. Metabolism and functions of glutathione in brain. Progress in neurobiology. 2000, 62(6), 649-671.
- NeuroMab™ Anti-TNFα BBB Shuttle Antibody(NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- NeuroMab™ Anti-Amyloid Beta 1-15 Antibody(NRP-0422-P867) (Cat#: NRP-0422-P867)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P515) (Cat#: NRP-0422-P515)
- NeuroMab™ Anti-GD2 Antibody(NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- NeuroMab™ Anti-pTau Antibody(NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- NeuroMab™ Anti-F-Spondin/SPON1 Antibody, Clone N24875P (CBP11839) (Cat#: NRZP-0822-ZP4740)
- NeuroMab™ Anti-Alpha Synuclein Antibody(NRP-0422-P614) (Cat#: NRP-0422-P614)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- NeuroMab™ Anti-SEZ6 Antibody(NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Human Hippocampal Neuron Cells HPPNCs (Cat#: NCL2110P106)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- AAV2/9-hEF1a-DIO-mCherry-P2A-TetTox-WPRE-pA (Cat#: NTA-2012-ZP268)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- AAV-mDLX-CRE-tdTomato (Cat#: NRZP-0622-ZP721)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- AAV2/2Retro-CAG-DIO-EGFP-2A-TetTox-pA [Neural Tracing] (Cat#: NTA-2012-ZP303)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- Dextran-CYanine5.5 (Cat#: NTA-2011-ZP118)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)